Zdrowie i gospodarka · 13/04/2011

FDA Releases Draft Guidance on Safety Labeling Changes for Drug and Biological Products

The Food and Drug Administration (FDA) has made available a draft guidance outlining the requirements for drug and biological product manufacturers to update safety labels in response to new safety information, as mandated by the 2007 Food and Drug Administration Amendments Act (FDAAA).